Bio Protocol Review 2026: A DeSci Launchpad for Funded Science

Bio Protocol is a decentralized science (DeSci) platform that calls itself a financial layer for commercializing research. Its homepage frames it as a place where science is researched, funded and brought to market, with four products: BIOS, OpenLabs, Launchpad and Biofy.

DefiLlama classifies it as a launchpad, tracks TVL of about $2.8 million across Ethereum and Base, and lists it since October 2025. The native token is BIO. The homepage says BIO is also available on Solana and BNB Chain.

The ecosystem includes DAOs focused on areas such as longevity, women's health, cryopreservation, rare disease and long COVID. The homepage gives three case studies: a post-training company, a peptides project and a hair loss program. These are the project's own claims and are not independently verified here.

Bio describes a loop in which science is researched, funded and sold, and what it earns flows back into research. In the research stage, BIOS and OpenLabs help scientists surface hypotheses, run experiments and find collaborators. In the funding stage, the Launchpad lets projects raise from a community and iterate with backers.

In the sell stage, Biofy turns validated research into products. Usage data and revenue flow back to researchers and backers. This is the model as the project presents it, and results vary by project.

The BIO token ties the system together. Holders stake BIO for veBIO to vote on upgrades and treasury assets. Staked BIO earns BioXP, which gives access to new project launches, and BIO is committed to back projects in their Ignition Sale. BIO is also the main pair asset for project tokens on decentralized exchanges, so project liquidity is tied to it.

Bio Protocol's fee schedule is not published publicly reviewed. The homepage does not list launchpad fees, Ignition Sale terms or staking costs.

One case study says a peptides project raised $50,000 and has received $112,000 in trading fees so far, which suggests trading fees can flow to projects. Users should check the official docs and each sale's terms for costs, plus normal network gas fees and exchange spreads when buying or bridging BIO.

DefiLlama lists no audits for Bio Protocol. Users interacting with the Launchpad, staking or bridging contracts carry smart-contract risk and should look for audit reports and security documentation in the project's official docs. The project does not describe any past incidents.

The launchpad involves buying early-stage project tokens, which can be illiquid and volatile. Public sources reviewed do not state the project's regulatory status, and rules on token sales vary by country, so check what applies where you live. Use your own wallet carefully and verify contract addresses before bridging or staking.

Bio Protocol is for crypto-literate users interested in DeSci who are comfortable with speculative, early-stage token sales and governance staking. It also suits researchers curious about community funding. It is not a fit for anyone who needs audited, low-risk, or liquid investments.